Reed Elsevier PLC
30 November 2006
News Release
Issued on behalf of Reed Elsevier PLC and Reed Elsevier NV
30 November 2006
APPOINTMENT OF JOINT CORPORATE BROKER
Reed Elsevier announces that it has appointed UBS Investment Bank to act as
joint corporate broker alongside JP Morgan Cazenove.
- ends -
Enquiries
Sybella Stanley Tel: +44 (0) 20 7166 5630
(Investors)
Patrick Kerr Tel: +44 (0) 20 7166 5646
(Media)
Notes to editors
Reed Elsevier Group plc
Reed Elsevier Group plc is a world leading publisher and information provider.
It is owned equally by its two parent companies, Reed Elsevier PLC and Reed
Elsevier NV. The parent companies are listed on the London, Amsterdam and New
York Stock Exchanges, under the following ticker symbols: London: REL; Amsterdam
: REN; New York: RUK and ENL. In 2005, Reed Elsevier made adjusted profit before
taxation of £1,002 million on turnover of £5,166 million. The group employs
36,000 people, including approximately 20,000 in North America. Operating in the
scientific, legal, educational and business-to-business sectors, Reed Elsevier
provides high value and flexible information solutions to professional end
users, with increasing emphasis on internet delivery. For further information,
please visit the company website www.reedelsevier.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.